Tahziba Hussain

Dr. Tahziba Hussain

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Emerging Microbes & Infections
Verified
Journal Article
Open access
Shasank Sekhar SwainShasank Sekhar Swain
Shasank Sekhar Swain
DSDivakar Sharma
Divakar Sharma
THTahziba Hussain
Tahziba Hussain
SPSanghamitra Pati
Sanghamitra Pati
Nowadays, drug-resistant tuberculosis (DR-TB) and co-infected tuberculosis (CI-TB) strains are the leading cause for the enhancement of long-term morbidity and unpredicted mortality rates from this ghoulish acid fast-bacterium infection, globally. Unfortunately, the lack of/ample lethargic towards the development of compelling anti-TB regimens with a large-scale prevalence rate is a great challenge towards control of the pandemic situation. Indeed, the recent improvement in genomic studies for early diagnosis and understanding the mechanisms of drug resistance, as well as the identification of newer drug targets is quite remarkable and promising. Mainly, identification of such genetic factors, chromosomal mutations and associated pathways gives new ray of hope in current anti-TB drug discovery. This focused review provides molecular insights into the updated drug resistance mechanisms with encoded bacilli genetic factors as a novel target and potential source of development with screened-out newer anti-TB agents towards the control of MDR-TB soon.

17 February 2017 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
NMNityananda Mandal
Nityananda Mandal
PAParveen Kumar Anand
Parveen Kumar Anand
SGSubhash Gautam
Subhash Gautam
SDShritam Das
Shritam Das
THTahziba Hussain
Tahziba Hussain
Tuberculosis (TB) is a major public health problem, invading all age groups world-wide. It is an opportunistic infection affecting the individuals alone or with co-infections. Childhood TB is a neglected aspect and a significant health problem in epidemic areas. It constitutes more than 20% of TB incidence. Pediatric TB exists in the shadow of adult TB. The clinicians concentrate on pulmonary manifestation of TB, whereas it is a major problem in both pulmonary and extra-pulmonary infections. The rate of infection with this disease is mostly associated with poverty, social disruption and human immunodeficiency virus (HIV) infection. The diagnosis of extra-pulmonary TB (EPTB) is more difficult than pulmonary TB (PTB). Delayed diagnosis and executive treatment contribute to increase in the mortality rate in endemic areas. This article provides the evidence-based simple and safe screening method, indicating rapid, highly sensitive and specific diagnostic tests for pulmonary and EPTB in children. The most important aspect of treatment is the correct course of anti-tubercular drugs. This review serves the purpose of quick reference for microbiologists, epidemiologists, academicians, students and researchers. It provides guidance regarding early diagnosis and treatment accuracy of pediatric TB.

1 September 2006 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
THTahziba Hussain
Tahziba Hussain
KKK.K. Kulshreshtha
K.K. Kulshreshtha
SSShikha Sinha
Shikha Sinha
VYV.S. Yadav
V.S. Yadav
VKV.M. Katoch
V.M. Katoch

4 February 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Shasank Sekhar SwainShasank Sekhar Swain
Shasank Sekhar Swain
SPSanghamitra Pati
Sanghamitra Pati
THTahziba Hussain
Tahziba Hussain

1 January 2007 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
THTahziba Hussain
Tahziba Hussain
A quick glance at this review article provides an insight into the common and different features of M. leprae and M. tuberculosis and the diseases caused by these organisms. Table I provides the popular names, history, stigma, description of the disease, clinical features, classification and the types of disease manifestations, who are affected, Signs and Symptoms, Clinical examination, treatment regimens, reactions, relapses, immunity, infectiousness, risk groups, deformities, sequelae, transmission, prevention, complications, vaccination, laboratory studies, days of importance for both the diseases. Table II provides information regarding the causative organisms, M. leprae and M. tuberculosis, their size, genome, protein coding region, lost genes, pseudogenes, classification, predilection, incubation period, ecology, cell structure, metabolism, resistance, bacterial index, growth in vitro, experimental animals, etc. Table III provides figures of M. leprae and M. tuberculosis, their genome, Lepromin and Tuberculin testing, Global scenario, Indian scenario, colonies of M. leprae and M. tuberculosis, drugs for treatment of tuberculosis and leprosy (MDT blister pack), and so on.

13 April 2022 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
Shasank Sekhar SwainShasank Sekhar Swain
Shasank Sekhar Swain
SSSatya R. Singh
Satya R. Singh
ASAlaka Sahoo
Alaka Sahoo
Pritam Kumar PandaPritam Kumar Panda
Pritam Kumar Panda
THTahziba Hussain
Tahziba Hussain
SPSanghamitra Pati
Sanghamitra Pati